Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.35 | -$0.06 | -$0.21 |
| Q2 2026 | 2 | -$0.17 | -$0.12 | -$0.15 |
| Q3 2026 | 1 | -$0.10 | -$0.06 | -$0.08 |
| Q4 2026 | 1 | $0.00 | $0.02 | $0.01 |
| Q1 2027 | 1 | -$0.03 | -$0.02 | -$0.03 |
| Q2 2027 | 1 | -$0.05 | -$0.04 | -$0.04 |
| Q3 2027 | 1 | $0.01 | $0.02 | $0.02 |
| Q4 2027 | 1 | $0.06 | $0.06 | $0.06 |
| Q1 2028 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2028 | 1 | $0.08 | $0.10 | $0.09 |
| Q3 2028 | 1 | $0.08 | $0.10 | $0.09 |
| Q4 2028 | 1 | $0.11 | $0.13 | $0.12 |
LifeMD Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $-0.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.14571 by $0.01429. The company had revenue of 47.28 M for the quarter and had revenue of 194.06 M for the year. LifeMD Inc has generated $0 earnings per share over the last year ($-0.23 diluted earnings per share) and currently has a price-to-earnings ratio of -7.02. LifeMD Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | -$0.15 | -$0.16 | -0.01 | $49.16 M | $47.28 M |
| 05/06/2026 | Q1 2026 | -$0.14 | -$0.20 | -0.06 | $48.84 M | $50.16 M |
| 03/10/2026 | Q4 2025 | N/A | -$0.05 | N/A | $45.82 M | $46.87 M |
| 11/17/2025 | Q3 2025 | -$0.06 | -$0.10 | -0.04 | $62.09 M | $60.17 M |
| 08/05/2025 | Q2 2025 | N/A | -$0.06 | N/A | $66.34 M | $62.22 M |
| 05/06/2025 | Q1 2025 | -$0.04 | $0.01 | 0.05 | $62.46 M | $65.70 M |
| 03/11/2025 | Q4 2024 | N/A | -$0.02 | N/A | $57.47 M | $64.25 M |
| 11/07/2024 | Q3 2024 | -$0.12 | -$0.14 | -0.02 | $53.82 M | $53.27 M |
| 08/07/2024 | Q2 2024 | -$0.12 | -$0.17 | -0.05 | $48.46 M | $50.66 M |
| 05/08/2024 | Q1 2024 | -$0.15 | -$0.17 | -0.02 | $42.59 M | $44.14 M |
| 03/11/2024 | Q4 2023 | -$0.14 | -$0.10 | 0.04 | $41.30 M | $44.86 M |
| 11/08/2023 | Q3 2023 | -$0.15 | -$0.18 | -0.03 | $38.44 M | $38.61 M |
| 08/09/2023 | Q2 2023 | -$0.10 | -$0.21 | -0.11 | $35.15 M | $35.95 M |
| 05/12/2023 | Q1 2023 | -$0.16 | -$0.32 | -0.16 | $30.81 M | $33.13 M |
| 03/22/2023 | Q4 2022 | -$0.18 | -$0.37 | -0.19 | $33.58 M | $28.12 M |
| 11/10/2022 | Q3 2022 | -$0.27 | -$0.27 | 0 | $31.85 M | $31.41 M |
| 08/11/2022 | Q2 2022 | -$0.23 | -$0.43 | -0.2 | $31.31 M | $30.46 M |
| 05/13/2022 | Q1 2022 | -$0.26 | -$0.44 | -0.18 | $31.53 M | $29.04 M |
| 03/07/2022 | Q4 2021 | -$0.39 | -$0.68 | -0.29 | $27.46 M | $27.42 M |
| 11/10/2021 | Q3 2021 | -$0.49 | -$0.54 | -0.05 | $25.28 M | $24.95 M |
The conference call for LifeMD Inc's latest earnings report can be listened to online.
The conference call transcript for LifeMD Inc's latest earnings report can be read online.
LifeMD Inc (:LFMD) has a recorded annual revenue of $194.06 M.
LifeMD Inc (:LFMD) has a recorded net income of $-7,106,359.LifeMD Inc has generated $-0.23 earnings per share over the last four quarters.
LifeMD Inc (:LFMD) has a price-to-earnings ratio of -7.02 and price/earnings-to-growth ratio is 0.07.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED